Europe
Lessons from the Bayer Case
Lobbyists for the drugs industry have learned something from the health crisis that obliged Bayer to withdraw its anti-cholesterol drug: shift legal responsibility to patients by informing them more about the medicine. [...]
Published on 20.09.2001 at 10:00 GMT
Reading time 2 minutes
Read this article here:
15% OFF your subscription
Special offer: Only 7d and 1h to take advantage of it
This offer is open to all new subscribers and runs until 26/04/2024